Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial

The narrow range of choice and virus resistance to the most common drugs require search and introduction of new drugs with proven efficacy and safety for the treatment of influenza. Ergoferon is a new combined medicine containing release active antibodies to interferon-γ (anti-IFNγ), CD4-coreceptor...

Descrizione completa

Dettagli Bibliografici

Autori principali:	A. V. Averyanov, A. P. Babkin, B. Ya. Bart, A. L. Volchetsky, E. S. Minina, O. A. Kozyrev, M. P. Kostinov, D. V. Petrov, E. P. Selkova, M. A. Putilovsky, V. B. Nechaev, O. I. Epstein, E. N. Andrianova
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	LLC "Publishing House OKI" 2020-05-01
Serie:	Антибиотики и Химиотерапия
Soggetti:	influenza antiviral drugs fever ergoferon release active antibodies
Accesso online:	https://www.antibiotics-chemotherapy.ru/jour/article/view/445
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!